Yang et al. identified MMP11 as a key cancer driver in lung adenocarcinoma and, furthermore, as a potential target for antibody therapy as application of anti-MMP11 antibodies suppressed the growth of tumours in xenograft models [35]. Here, MMP11 is linked to neoplasm.